190 related articles for article (PubMed ID: 14565597)
21. GRK2 and beta-arrestin 1 as negative regulators of thyrotropin receptor-stimulated response.
Iacovelli L; Franchetti R; Masini M; De Blasi A
Mol Endocrinol; 1996 Sep; 10(9):1138-46. PubMed ID: 8885248
[TBL] [Abstract][Full Text] [Related]
22. Beta-arrestin- and G protein receptor kinase-mediated calcium-sensing receptor desensitization.
Pi M; Oakley RH; Gesty-Palmer D; Cruickshank RD; Spurney RF; Luttrell LM; Quarles LD
Mol Endocrinol; 2005 Apr; 19(4):1078-87. PubMed ID: 15637145
[TBL] [Abstract][Full Text] [Related]
23. Expression of beta-arrestins in toxic and cold thyroid nodules.
Voigt C; Holzapfel H; Paschke R
FEBS Lett; 2000 Dec; 486(3):208-12. PubMed ID: 11119705
[TBL] [Abstract][Full Text] [Related]
24. Double life: How GRK2 and β-arrestin signaling participate in diseases.
Zhai R; Snyder J; Montgomery S; Sato PY
Cell Signal; 2022 Jun; 94():110333. PubMed ID: 35430346
[TBL] [Abstract][Full Text] [Related]
25. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ
Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578
[TBL] [Abstract][Full Text] [Related]
26. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
Wang L; Liu S; Quarles LD; Spurney RF
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
[TBL] [Abstract][Full Text] [Related]
27. Uncoupling and endocytosis of 5-hydroxytryptamine 4 receptors. Distinct molecular events with different GRK2 requirements.
Barthet G; Gaven F; Framery B; Shinjo K; Nakamura T; Claeysen S; Bockaert J; Dumuis A
J Biol Chem; 2005 Jul; 280(30):27924-34. PubMed ID: 15919661
[TBL] [Abstract][Full Text] [Related]
28. Beta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2.
Penela P; Elorza A; Sarnago S; Mayor F
EMBO J; 2001 Sep; 20(18):5129-38. PubMed ID: 11566877
[TBL] [Abstract][Full Text] [Related]
29. Real-time detection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2.
Hasbi A; Devost D; Laporte SA; Zingg HH
Mol Endocrinol; 2004 May; 18(5):1277-86. PubMed ID: 14976224
[TBL] [Abstract][Full Text] [Related]
30. Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2/6 and beta-arrestin-2 in postmortem brains of opiate addicts.
Ferrer-Alcón M; La Harpe R; García-Sevilla JA
Brain Res Mol Brain Res; 2004 Feb; 121(1-2):114-22. PubMed ID: 14969742
[TBL] [Abstract][Full Text] [Related]
31. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
Wang L; Quarles LD; Spurney RF
J Bone Miner Res; 2004 Oct; 19(10):1661-70. PubMed ID: 15355561
[TBL] [Abstract][Full Text] [Related]
32. β-arrestin-selective G protein-coupled receptor agonists engender unique biological efficacy in vivo.
Gesty-Palmer D; Yuan L; Martin B; Wood WH; Lee MH; Janech MG; Tsoi LC; Zheng WJ; Luttrell LM; Maudsley S
Mol Endocrinol; 2013 Feb; 27(2):296-314. PubMed ID: 23315939
[TBL] [Abstract][Full Text] [Related]
33. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
34. β-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation.
Boutin A; Eliseeva E; Gershengorn MC; Neumann S
FASEB J; 2014 Aug; 28(8):3446-55. PubMed ID: 24723693
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of beta-arrestin 1 and beta-arrestin 2 gene expression in rat brain by morphine.
Fan XL; Zhang JS; Zhang XQ; Yue W; Ma L
Neuroscience; 2003; 117(2):383-9. PubMed ID: 12614678
[TBL] [Abstract][Full Text] [Related]
36. Multiple functions of G protein-coupled receptor kinases.
Watari K; Nakaya M; Kurose H
J Mol Signal; 2014 Mar; 9(1):1. PubMed ID: 24597858
[TBL] [Abstract][Full Text] [Related]
37. Regulation of PTH1 receptor expression by uremic ultrafiltrate in UMR 106-01 osteoblast-like cells.
Disthabanchong S; Hassan H; McConkey CL; Martin KJ; Gonzalez EA
Kidney Int; 2004 Mar; 65(3):897-903. PubMed ID: 14871409
[TBL] [Abstract][Full Text] [Related]
38. Real-time visualization of the cellular redistribution of G protein-coupled receptor kinase 2 and beta-arrestin 2 during homologous desensitization of the substance P receptor.
Barak LS; Warabi K; Feng X; Caron MG; Kwatra MM
J Biol Chem; 1999 Mar; 274(11):7565-9. PubMed ID: 10066824
[TBL] [Abstract][Full Text] [Related]
39. Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin.
Appleyard SM; Celver J; Pineda V; Kovoor A; Wayman GA; Chavkin C
J Biol Chem; 1999 Aug; 274(34):23802-7. PubMed ID: 10446141
[TBL] [Abstract][Full Text] [Related]
40. Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors.
Zhang X; Wang F; Chen X; Li J; Xiang B; Zhang YQ; Li BM; Ma L
J Neurochem; 2005 Oct; 95(1):169-78. PubMed ID: 16181421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
